The Mosquito Network: Collaborative Entrepreneurship in the Fight to Eliminate Malaria Deaths (A) Custom Case Solution & Analysis

1. Evidence Brief: The Mosquito Network

Financial Metrics

Investment Scale: The Bill and Melinda Gates Foundation (BMGF) committed 1.9 billion dollars to malaria efforts by 2011 (Exhibit 1).
Disease Burden: Malaria causes approximately 655,000 deaths annually, with 91 percent occurring in Africa (Case Text, Section 1).
Economic Impact: Malaria accounts for an estimated 40 percent of public health expenditure in high-burden countries (Case Text, Section 2).
Funding Source: PATH MACEPA received 168 million dollars from BMGF to demonstrate that malaria could be eliminated in specific geographies (Exhibit 4).

Operational Facts

Strategy Model: The surveillance-to-response model requires identifying every malaria case and treating the individual plus the surrounding household (Paragraph 12).
Interventions: Primary tools include long-lasting insecticide-treated nets (LLINs), indoor residual spraying (IRS), and rapid diagnostic tests (RDTs) (Paragraph 15).
Geographic Focus: Initial demonstration projects centered in Zambia, focusing on Southern Province (Case Text, Section 4).
Network Composition: Includes international NGOs (PATH), academic institutions, private sector manufacturers, and National Malaria Control Programs (NMCPs) (Exhibit 5).

Stakeholder Positions

Bill Gates (BMGF): Advocates for total eradication rather than mere control; views malaria as a solvable engineering problem (Paragraph 4).
Regina Rabinovich (BMGF): Emphasizes the need for a collaborative network to bridge the gap between discovery and delivery (Paragraph 18).
Kent Campbell (PATH): Focuses on operationalizing scale; insists that data must drive every intervention decision (Paragraph 22).
African Ministries of Health: Balance malaria goals against other health priorities like HIV/AIDS and primary care (Paragraph 31).

Information Gaps

Unit Costs: The case lacks specific per-capita costs for the surveillance-to-response model at various scales.
Private Sector Incentives: Limited data on the profit margins required for manufacturers to sustain R&D for new insecticides.
Sustainability: No financial projections for how national governments will fund the network once BMGF or Global Fund support decreases.

2. Strategic Analysis

Core Strategic Question

How can the Mosquito Network transition from a foundation-funded demonstration project to a sustainable, state-led global eradication infrastructure without losing operational momentum?

Structural Analysis

Value Chain Analysis: The malaria eradication value chain is currently fragmented. Innovation (R&D) is concentrated in Western labs, while Delivery (Implementation) resides with local health workers. The middle link—Data and Surveillance—is the bottleneck. Without real-time data, the supply chain for nets and drugs remains reactive, leading to stock-outs or waste.

Jobs-to-be-Done: For African Ministries of Health, the job is not just killing mosquitoes; it is strengthening health systems. The current network focuses heavily on malaria-specific tools, which may create friction with broader public health objectives.

Strategic Options

Option 1: Centralized Technology Integration
Build a unified, cross-national data platform managed by PATH to track every case in the network. This ensures MECE data collection but requires significant sovereign concessions on health data ownership.

Option 2: Market-Driven Incentive Model
Shift from funding interventions to purchasing outcomes. BMGF and partners would offer tiered rewards to governments for achieving verified malaria-free zones. This reduces the need for direct management but risks data falsification.

Option 3: Decentralized Regional Hubs
Transfer the Mosquito Network leadership to regional African centers of excellence. This builds local capacity and ensures cultural alignment but may result in inconsistent execution quality across borders.

Preliminary Recommendation

Pursue Option 3. Eradication is a local execution challenge, not a global R&D challenge. By shifting the center of gravity to regional African hubs, the network addresses the political sustainability risk. The BMGF should pivot from being the central architect to being the primary financier of a locally-governed technical secretariat.

3. Implementation Roadmap

Critical Path

Month 1-3: Audit current data interoperability between the Zambian NMCP and the PATH MACEPA platform.
Month 4-6: Establish a Regional Technical Secretariat in Lusaka to oversee Southern African cross-border surveillance.
Month 7-12: Transition procurement responsibilities for RDTs and LLINs from PATH to national health supply chains with embedded quality control auditors.

Key Constraints

Talent Availability: The surveillance-to-response model requires high-level epidemiological skills at the district level, which are currently in short supply.
Regulatory Friction: Cross-border movement of health workers and data faces legal hurdles in the SADC region.

Risk-Adjusted Implementation Strategy

To mitigate the risk of operational failure during the transition, the network must maintain a shadow management structure for 24 months. Funding should be released in tranches tied to data accuracy audits rather than intervention coverage. If a local hub fails to report cases for two consecutive months, the central technical team resumes direct oversight to prevent a resurgence of infections.

4. Executive Review and BLUF

BLUF

The Mosquito Network must move beyond the demonstration phase by transferring operational ownership to regional African authorities. The current model relies too heavily on BMGF funding and PATH management, creating a structural dependency that threatens long-term eradication. Success requires shifting from a project-based approach to a permanent health infrastructure. The recommendation is to fund regional secretariats that integrate malaria surveillance into general health systems. This ensures that the tools developed by the network remain functional after the foundation exits. Speed is essential because parasite resistance to current drugs is increasing. The network must execute now or face a permanent loss of efficacy in its primary interventions.

Dangerous Assumption

The analysis assumes that national governments will prioritize malaria eradication over other urgent health crises once the immediate death rate drops. Historical evidence suggests that when a disease becomes less visible, political will and funding evaporate, leading to resurgence.

Unaddressed Risks

Biological Resistance: The strategy relies on chemical interventions (IRS and LLINs). The probability of widespread mosquito resistance to pyrethroids is high, which would invalidate the current operational model.
Political Instability: The surveillance-to-response model requires total geographic access. Conflict in any participating region creates a reservoir for the parasite, rendering the network's efforts in neighboring areas temporary.

Unconsidered Alternative

The team did not evaluate a private-sector retail model. Instead of relying on government distribution, the network could subsidize a commercial supply chain for diagnostics and treatment, utilizing existing kiosks and pharmacies to reach the 40 percent of the population that bypasses public clinics.